This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The study is expected to be the world’s first Phase 2a clinicaltrial evaluating the efficacy of psilocybin and psychotherapy to treat fibromyalgia. The open-label Phase 2a clinicaltrial will evaluate the efficacy of TRYP-8802, an oral formulation of synthetic psilocybin, in tandem with psychotherapy for treating fibromyalgia.
The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronicpain. billion, servicing nearly 340,000 active patients.
Research Team to Study the Impact of CBD on Spinal Injury Pain. Professor Luke Henderson is set to be the study’s lead investigator and he explains that the unfortunate truth for more than half of spinal cord injury patients is the development of chronicpain. Lambert Initiative experts have won $1.7
The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.
Enters into the ChronicPain Market with Psychedelics. binding letter of intent signed on July 12th 2021 to purchase certain assets of Cannvalate Pty Ltd. (“Shanti”), and all its assets focused on psychedelic MDMA-based drug development. The global chronicpain treatment market is predicted to progress at a CAGR of 6.5%
. – July 8, 2019 /Canna Newswire/ – The Colorado-based Canna Research Group developed The Athlete Pain, Exercise, and Cannabis Experience (PEACE) Survey study for active adults to look beyond the stigma of cannabis use in athletes. She is the Founder & CEO of Canna Research Group. About Canna Research Group.
. – July 8, 2019 /Canna Newswire/ – The Colorado-based Canna Research Group developed The Athlete Pain, Exercise, and Cannabis Experience (PEACE) Survey study for active adults to look beyond the stigma of cannabis use in athletes. She is the Founder & CEO of Canna Research Group. About Canna Research Group.
A recent study , funded by the National Institute on Drug Abuse (NIDA) and published in JAMA Network Open , reported a correlation between obtaining a medical marijuana (MMJ) card and developing CUD. Despite being published in a reputable journal, there are questions about the legitimacy of the research. ClinicalTrial Sample Size.
Pharmaceutical companies use artificial intelligence (AI) to sort through reams of scientific data to find potentially effective active ingredients to be developed into approved drugs. RYAH’s database provides that type of scale to all parties involved – patients, doctors, researchers, drug developers, growers, etc.
In this article, we’ll talk about a few of the most common conditions for which medical marijuana is prescribed, exploring the growing body of research and real-world experiences that contribute to its acceptance as a viable therapeutic option. Medical marijuana, however, has emerged as a potential alternative.
Study Results Indicate SCI-160 Has A Significant Analgesic Effect on Acute and ChronicPain. Key findings from the pre-clinicaltrial are as follows: SCI-160 significantly alleviates pain up to 6 hours after injection as compared with vehicle-treated animals. TEL AVIV, Israel , Aug. after injection.
Additionally, no current treatments can reverse existing neurological damage, highlighting the need for ongoing research into more effective therapies and potential cures. THC and CBD interact with pain receptors in the CNS and peripheral nervous system, providing relief without the same risk of dependence as opioid medications.
Flora Pharma’s objective is to create and leverage a proprietary drug development platform in collaboration with an artificial intelligence and machine learning group to identify new bioactive compounds within the cannabis plant that interact with certain gene targets responsible for specific disease states and conditions.
OTCQB: SILO) a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, is pleased to announce that it has entered into a Scientific Research Agreement (SRA) with the University of California San Francisco (UCSF). Englewood Cliffs, NJ, June 08, 2021 (GLOBE NEWSWIRE) — Silo Pharma, Inc.
As cannabis legalisation spreads, research has found considerable use in for cannabis in medicine. One particularly promising area of research is in the treatment of cancer. Doctors prescribe various forms of opiods to cancer patients for pain. Spain researches advanced use of cannabis medications.
We are humbled to introduce you to them and their exceptional ideas, ranging from community grassroots mental health efforts designed to empower historically vulnerable communities of color, to research plans for identifying strain specific genetics. Veriheal’s Innovation in Cannabis Scholarship 2020 Winners . Nishtha Tripathi.
Over time, medical marijuana for managing neuropathic pain has gained attention as an encouraging alternative, thanks to the positive outcomes many patients have experienced. This article explores various aspects of using medical marijuana to alleviate neuropathic pain, offering tips and insights based on the latest medical research.
Similar to ketamine, psilocybin has shown great promise in clinicaltrials for helping to effectively treat depression and PTSD (and we’ve written about psilocybin several times on this blog, including here and here ). major depressive disorder, post-traumatic stress disorder, acute suicidality).
Santé Cannabis, a pioneer in medical cannabis in Québéc , has partnered with Spectrum Therapeutics, the medical division of Canopy Growth (TSX: WEED) (NYSE: CGC) to launch the Prescriber Training Program, designed to aid physicians and patients, announced today at the new Santé Cannabis clinic and research centre in Montréal.
(Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced that it intends to initiate dosing for a Phase 2 trial of MYMD-1’s function in delaying aging early in the fourth quarter of 2021. in the blood. About MyMD Pharmaceuticals, Inc. 646) 421-9523.
The sale will accelerate the development of Gb Sciences’ proprietary Parkinson’s disease and COVID-related Cytokine-Release Syndrome therapies. “We have emerged from this sale as a pure-play biopharmaceutical research and development company. LAS VEGAS, Jan. 11, 2022 (GLOBE NEWSWIRE) — Gb Sciences, Inc.
Chronicpain conditions, such as arthritis or back pain, can cause discomfort that interferes with sleep. It has shown effectiveness in helping individuals develop better sleep habits and manage insomnia symptoms without relying on medication. excessive noise or light), can also disrupt the natural sleep-wake cycle.
(Tree of Knowledge) (CSE:TOKI) (OTC:TOKIF) expands global medical marijuana and CBD research in partnership with the Caribbean Institute of Pharmacy Policy (CIPPPAR) in Jamaica. Tree of Knowledge will be introducing chronicpain management protocols and research into the Caribbean market.
These two cannabinoids represent just a fraction of the compounds within the cannabis plant, and ongoing research continues to uncover the potential of other lesser-known cannabinoids. Therapeutic Effects of Cannabinoids Pain Relief: Perhaps one of the most recognized therapeutic effects of cannabinoids is pain relief.
– Multiple Contracts Awarded to Support the Development and Manufacturing of Envelta (NES100) – BERWYN, Pa.–(BUSINESS Envelta is Virpax’s endogenous enkephalin intranasal spray for acute and chronicpain, including pain associated with cancer. In October 2021, Virpax announced that a $1.87
The steadily aging population across the globe has played a significant role in driving the demand for medical cannabis as geriatric patients are more likely to developchronic illnesses and require more physician visits. 12 Overview of ClinicalResearch Suggesting the Benefits of Medical Cannabis Across Various Indications.
Virpax” or the “Company”) (NASDAQ:VRPX), today announced its financial results for the three and nine months ended September 30, 2021, and other recent developments. “We Our lead product candidate is Envelta™, which utilizes MET to deliver enkephalin nanoparticles for acute and chronicpain including pain associated with cancer.
As cannabis legalisation spreads, research has found considerable use in for cannabis in medicine. One particularly promising area of research is in the treatment of cancer. Doctors prescribe various forms of opiods to cancer patients for pain. Spain researches advanced use of cannabis medications.
Further, numerous private companies have begun to research psychedelic therapy and develop new pharmaceutical compounds derived from psychedelic substances. In June 2021, similar measures were passed in Connecticut and Texas, where medical research on psilocybin is now also legal on a statewide level.
Under the terms of this agreement, Sinclair Research will perform preclinical animal studies including method, dosage and toxicity as part of the enabling trials for an Investigational New Drug Application (“IND”) for AnQlar, as required by the U.S. Food and Drug Administration (“FDA”).
The new Radicle Science-OBX alliance fills an unmet need for rigorous scientific research in the cannabis industry and sets a new gold standard for CBD and minor cannabinoid product development.
Now, psychedelic research is booming. And while most psychedelics are currently illegal in the United States and around the world, researchers are exploring their use in medicine to treat conditions such as depression, PTSD, addiction, anxiety, OCD, migraines, end of life acceptance of mortality, and eating disorders. 19 20 21 22 23.
Previously thought of as either a horse tranquilizer or a dissociative recreational party drug, ketamine has re-emerged as a promising therapeutic agent to treat pain, PTSD, depression, anxiety and more. This effect of opioids increasing the perception of pain is called opioid-induced hyperalgesia.
It’s when presented with personal stories like that of the Rhodes family and the stream of alarming data that the significance of Tetra Bio-Pharma’s (TBP) clinicaltrials is worth exploring. Rhodes acknowledges that as a mother and a healthcare practitioner, she is keen and open to understanding research done by TBP. “It
Recommendations for research. Chronicpain. Chronicpain. Do not offer the following to manage chronicpain in adults: nabilone. Do not offer CBD to manage chronicpain in adults unless as part of a clinicaltrial. Tools and resources. Recommendations. Rationale and impact.
The increasing research on medical marijuana shows its therapeutic value for a range of health conditions, including chronicpain, cancer, arthritis, diabetes, depression, anxiety, and many more. BX-1: Bionorica SE BX-1 is an oral solution containing dronabinol, being developed by Bionorica.
Dubbed by SFGate “The Coach Who Rolls the Best Blunts in the NBA,” Golden State Warriors Coach Steve Kerr has admitted to using marijuana to cope with nagging back pain. But it was worth it, because I’m searching for answers on pain. Morgan Freeman says only cannabis helps reduce his fibromyalgia pain (Shutterstock).
Virpax” or the “Company”) (NASDAQ:VRPX), a company specializing in developing product candidates for pain management, CNS disorders and anti-viral indications, has acquired the exclusive worldwide rights from Nanomerics Ltd. –Virpax to Expand Use of Molecular Envelope Platform Technology– BERWYN, Pa.–(BUSINESS
Medical Uses of THC Let’s explore the diverse medical uses of THC, highlighting its efficacy in alleviating chronicpain, its comparison with traditional painkillers, its role in combating nausea and stimulating appetite, its potential benefits for neurological disorders, and its complex interaction with mental health conditions.
VA scientists may conduct research on marijuana benefits and risks, and potential for abuse, under regulatory approval. Research suggests that marijuana may work in a number of different ways to decrease PTSD symptoms. VA pharmacies may not fill prescriptions for medical marijuana. You’re Not Alone.
Medical cannabis is making its way out of the haze and into the headlines as expanded research programs demonstrate its proven benefits. Some of the most recognized applications of cannabinoid-based medicine are in the treatment of neuropathic pain , inflammation and muscle spasticity. However, this is slowly changing.
After watching my brother self-medicate for his chronicpain for decades, I didn’t understand how cannabis was important to him as a medicine. I always thought he used his chronicpain as an “excuse” to self-administer what I thought was a toxic drug. . in 2014, I watched my brother walk into a cannabis clinic.
The proposed legislation seeks to amend existing laws and policies to allow VA healthcare providers to discuss medical marijuana with patients, conduct research on its efficacy, and prescribe medical cannabis in states where it is legal. Any questions related to research can be addressed to VHABLRD-CSRD@va.gov.
In drilling down the issue, a lack of UK-based research as to the efficacy of CBPMs is the starting point. Several laudable initiatives have sought to plug the research gap, including Project Twenty21, which is the UK’s largest observational medicinal cannabis study.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content